Biotech developing treatments for rare and ultra-rare genetic diseases.
Industry: Health Care
First Day Return: -23.6%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 02/07/2014 |
Offer Price | $11.00 |
Price Range $11.00 - $13.00 | |
Offer Shares (mm) | 3.2 |
Deal Size ($mm) | $35 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 07/30/2014 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $35 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Tel Aviv, Israel |
Founded | 2012 |
Employees at IPO | 6 |
Website www.bioblast-pharma.com |